(Q38082793)

28 August 2017

title

Hormone withdrawal-associated symptoms: overlooked and under-explored (English)

1 reference

28 August 2017

0 references

Johannes Bitzer

1

1 reference

28 August 2017

language of work or name

1 reference

20 February 2013

1 reference

Gynecological Endocrinology

28 August 2017

published in

1 reference

28 August 2017

volume

29

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

530-535

1 reference

Continuous oral contraception: changing times

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Nonspecific side effects of oral contraceptives: nocebo or noise?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Neuroendocrine aspects of migraine in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Suppression of estrogen-withdrawal headache with extended transdermal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Combined oral contraceptives in women with menstrual migraine without aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

A multicenter, randomized study of an extended cycle oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

New regimens with combined oral contraceptive pills--moving away from traditional 21/7 cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

Recommendations on the Risk of Ischaemic Stroke Associated With Use of Combined Oral Contraceptives and Hormone Replacement Therapy in Women With Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.760194

10.3109/09513590.2012.760194

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference